Additionally, Western blot analyses demonstrated that RAD51 expression levels were lower in MGMT-deficient NPC cells treated with CDDP compared with MGMT-proficient cells (Fig. 2a, b). This evidence concerns the gene MGMT and nasopharyngeal carcinoma.